Date: 2025/05/19 - 22:32
Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly. Participants who received tirzepatide also had greater improvements in metabolic risk factors. Tirzepatide's dual effects on GLP-1 and GIP may explain its superior performance.
Date: 2025/05/15 - 23:32
Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss medication Wegovy. Experts say an oral medication for weight loss might be more cost effective and easier for people to use.
Date: 2025/05/12 - 22:00
A 3-month time-restricted eating (TRE) protocol resulted in up to one year of sustained weight loss in people with overweight or obesity. Adhering to an 8-hour window of eating led to greater weight loss than eating throughout the day, whether early or late.
Date: 2025/05/07 - 23:32
Researchers have developed a method for measuring the heart's “functional age” to help predict complications like heart disease. According to the authors of a new study, premature aging of the heart is linked to unhealthy lifestyle habits.
Date: 2025/05/02 - 00:32
A new study says plastics found in common household products can increase the risk of cardiovascular disease in people ages 55 to 64. Experts say you can reduce your exposure to microplastics by avoiding processed foods and not using plastic utensils or bowls.